Elite Pharmaceuticals Inc (ELTP)

[Hike]

Chris Dick - Elite Pharmaceuticals, Inc. - COO and President

First of all, Socius -- we may do it with Socius; we may do a different deal. We are evaluating alternatives, so that's open.
But the opportunities with abuse resistant sort of span a range of ANDAs to NDAs and bioequivalent studies to full efficacy studies, so it allows us to do the ANDA opportunities -- some of the ANDA opportunities and even a 505(b)(2) opportunity. And so we can certainly, I think, handle those things in-house if we raise this money through Socius.